Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    FP-CIT
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of F-18 FPCIT PET in Parkinson's Disease and Essential Tremor Patients
Condition: Parkinson's Disease
Interventions: Procedure: PET/CT;   Drug: F-18 FPCIT
2 Completed Prognostic Value of FP-CIT-SPECT in Parkinson´s Disease
Condition: Parkinson´s Disease
Intervention:
3 Completed Dopaminergic Loss and Pain in Parkinson's Disease
Conditions: Parkinson's Disease;   Pain
Intervention: Drug: ioflupane 123I (DATSCAN®)
4 Completed Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
5 Recruiting Gait and REM Sleep Behavior Disorder
Conditions: Parkinson's Disease;   REM Sleep Behavior Disorder
Interventions: Radiation: FP-CIT single-photon emission computed tomography;   Behavioral: neuropsychological evaluation;   Other: Gait recording with sensors
6 Completed Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects
Condition: Parkinson Disease
Interventions: Radiation: Group A - Early Imaging;   Radiation: Group B - Delayed Imaging
7 Completed Diet, Insulin Sensitivity And the Brain
Conditions: Obesity;   Diabetes Mellitus Type 2
Interventions: Other: Meal size increase with HFHS;   Other: Meal size increase with HS;   Other: Meal frequency increase with HFHS;   Other: Meal frequency increase with HS
8 Enrolling by invitation Non-motor Symptoms and Brain Dopamine Transporter Binding
Conditions: Parkinson Disease;   Parkinsonism
Intervention: Other: DAT SPECT imaging
9 Completed Constitution of a Standardized Neural Imaging Database in Healthy Subjects
Condition: Healthy
Intervention: Procedure: SPET, PET and MRI
10 Recruiting Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999
Condition: Idiopathic Parkinson Disease
Intervention: Drug: [18F] LBT-999 PET

Indicates status has not been verified in more than two years